Identification and stereochemical assignment of the β- hydroxytryptophan intermediate in the echinomycin biosynthetic pathway

Organic Letters

Volumn 8, Issue 21, 2006, Pages 4719-4722

  Koketsu, Kento ^a   Oguri, Hiroki ^a   Watanabe, Kenji ^b   Oikawa, Hideaki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 QUINOXALINECARBOXYLIC ACID; 5 HYDROXYTRYPTOPHAN; ECHINOMYCIN; QUINOXALINE DERIVATIVE; QUINOXALINE-2-CARBOXYLIC ACID;

ARTICLE; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; STEREOISOMERISM; STREPTOMYCES;

5-HYDROXYTRYPTOPHAN; ECHINOMYCIN; MOLECULAR STRUCTURE; QUINOXALINES; STEREOISOMERISM; STREPTOMYCES;

EID: 33750344073     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol061738+     Document Type: Article

References (37)

1. (a) Katagin, K.; Yoshida, T.; Sato, K. Quinoxaline antibiotics. In Antibiotics: Mechanism of Action of Antimicrobial and Antitumour Agents; Corcoran, J. W., Hahn, F. E., Eds.; Springer-Verlag: Heidelberg, 1975; Vol. 3, pp 234-251.
2. (b) Waring, M. J.; Fox, K. R. In Molecular Aspects of Anti-cancer Drug Action; Niedle, S., Waring, M. J., Eds.; Macmillan: New York, 1993; pp 127-156.
3. Boger, D. L.; Ichikawa, S.; Tse, W. C.; Hedrick, M. P.; Jin, Q. J. Am. Chem. Soc. 2001, 123, 561-568.
4. Dell, A.; Williams, D. H.; Morris, H. R.; Smith, G. A.; Feeney, J.; Roberts, G. C. K. J. Am. Chem. Soc. 1975, 97, 2497-2502.
5. Phillips, D. R.; White, R. J.; Trist, H.; Cullinane, C.; Dean, D.; Crothers, D. M. Anticancer Drug Des. 1990, 5, 21-29.
6. May, L. G.; Madine, M. A.; Waring, M. J. Nucleic Acids Res. 2004, 32, 65-72.
7. (a) Waring, M. J.; Wakelin, L. P. G. Nature 1974, 252, 653-657.
8. (b) Van Dyke, M. M.; Dervan, P. B. Science 1984, 225, 1122-1127.
9. (c) Ughetto, G.; Wang, A. H.; Quigley, G. J.; van der Marel, G. A.; van Boom, J. H.; Rich, A. Nucleic Acids Res. 1985, 13, 2305-2323.
10. (d) Cuesta-Seijo, J. A.; Sheldrick, G. M. Acta Crystallogr. 2005, D61, 442-448.
11. (a) Yoshida, T.; Katagiri, K. Biochemistry 1969, 8, 2645-2651.
12. (b) Reid, D. G.; Doddrell, D. M.; Williams, D. H.; Fox, K. R. Biochim. Biophys. Acta 1984, 798, 111-114.
13. (a) Gauvreau, D.; Waring, M. J. Can. J. Microbiol. 1984, 30, 439-450.
14. (b) Gauvreau, D.; Waring, M. J. Can. J. Microbiol. 1984, 30, 730-738.
15. (c) Gauvreau, D.; Swift, I. E.; Waring, M. J. Can. J. Microbiol. 1986, 32, 363-372.
16. For recent reviews, see: (a) Sieber, S. A.; Marahiel, M. A. Chem. Rev. 2005, 105, 715-738.
17. (b) Fischbach, M. A.; Walsh, C. T. Chem. Rev. 2006, 106, 3468-3496.
18. (a) Glund, K.; Schlumbohm, W.; Bapat, M.; Keller, U. Biochemistry 1990, 29, 3522-3527.
19. (b) Schmoock, G.; Pfennig, F.; Jewiarz, J.; Schlumbohm, W.; Laubinger, W.; Schauwecker, F.; Keller, U. J. Biol. Chem. 2005, 280, 4339-4349.
20. Watanabe, K.; Hotta, K.; Praseuth, A. P.; Koketsu, K.; Migita, A.; Boddy, C. N.; Wang, C.-C. C.; Oguri, H.; Oikawa, H. Nat. Chem. Biol. 2006, 2, 423-428.
21. Recently, identification of the biosynthetic cluster of the structurally related depsipeptide thiocoraline has been reported, in which a distinct transformation of L-tryptophan into a heteroacromatic carboxylic acid, 3-hydroxyl-quinaldic acid, was proposed; see: Lombo, F.; Velasco, A.; Castro, A.; de la Calle, F.; Brana, A. F.; Sanchez-Puelles, J. M.; Mendez, C.; Salas, J. A. ChemBioChem 2006, 7, 366-376.
22. For type II thioesterases associated with NRPS, see: (a) Schwarzer, D.; Mootz, H. D.; Linne, U.; Marahiel, M. A. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 14083-14088.
23. (b) Yeh, E.; Kohli, R. M.; Bruner, S. D.; Walsh, C. T. ChemBioChem 2004, 5, 1290-1293.
24. Chen, H.; Walsh, C. T. Chem. Biol. 2001, 8, 301-312.
25. Chen, H.; Hubbard, B. K.; O'Connor, S. E.; Walsh, C. T. Chem. Biol. 2002, 9, 103-112.
26. (a) Chen, H.; Thomas, M. G.; O'Connor, S. E.; Hubbard, B. K.; Burkart, M. D.; Walsh, C. T. Biochemistry 2001, 40, 11651-11659.
27. (b) Yin, X.; Zabriskie, T. M. ChemBioChem 2004, 5, 1274-1277.
28. (c) Ju, J.; Ozanick, S. G.; Shen, B.; Thomas, M. G. ChemBioChem 2004, 5, 1281-1285.
29. (d) Haltli, B.; Tan, Y.; Magarvey, N. A.; Wagenaar, M.; Yin, X.; Greenstein, M.; Hucul, J. A.; Zabriskie, T. M. Chem. Biol. 2005, 12, 1163-1168.
30. For enzymatic hydroxylations of tryptophan residues, see: Ito, S.; Takai, K.; Tokuyama, T.; Hayaishi, O. J. Biol. Chem. 1981, 256, 7834.
31. Fueki, S.; Tokiwano, T.; Toshima, H.; Oikawa, H. Org. Lett. 2004, 6, 2697-2700.
32. Amat, M.; Hadida, S.; Sathyanarayana, S.; Bosch, J. J. Org. Chem. 1994, 59, 10-11.
33. (a) Tao, B.; Schlingloff, G.; Sharpless, K. B. Tetrahedron Lett. 1998, 39, 2507-2510.
34. (b) Wen, S.-J.; Yao, Z.-J. Org. Lett. 2004, 6, 2721-2724.
35. Tao, J.; Hu, S.; Pacholec, M.; Walsh, C. T. Org. Lett. 2003, 5, 3223-3236.
36. Attempts to invert the C3-hydroxyl group under Mitsunobu conditions were unsuccessful.
37. Feldman, K. S.; Karatjas, A. G. Org. Lett. 2004, 6, 2849-2852.